The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.

The small GTPases of the Rho family comprising RhoA, Rac1 and Cdc42 function as molecular switches controlling several essential biochemical pathways in eukaryotic cells. Their activity is cycling between an active GTP-bound and an inactive GDP-bound conformation. The exchange of GDP to GTP is catal...

Full description

Bibliographic Details
Main Authors: Aniko Keller-Pinter, Bettina Ughy, Monika Domoki, Aladar Pettko-Szandtner, Tamas Letoha, Jozsef Tovari, Jozsef Timar, Laszlo Szilak
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5679609?pdf=render
_version_ 1818946945211695104
author Aniko Keller-Pinter
Bettina Ughy
Monika Domoki
Aladar Pettko-Szandtner
Tamas Letoha
Jozsef Tovari
Jozsef Timar
Laszlo Szilak
author_facet Aniko Keller-Pinter
Bettina Ughy
Monika Domoki
Aladar Pettko-Szandtner
Tamas Letoha
Jozsef Tovari
Jozsef Timar
Laszlo Szilak
author_sort Aniko Keller-Pinter
collection DOAJ
description The small GTPases of the Rho family comprising RhoA, Rac1 and Cdc42 function as molecular switches controlling several essential biochemical pathways in eukaryotic cells. Their activity is cycling between an active GTP-bound and an inactive GDP-bound conformation. The exchange of GDP to GTP is catalyzed by guanine nucleotide exchange factors (GEFs). Here we report a novel regulatory mechanism of Rac1 activity, which is controlled by a phosphomimetic (Ser179Glu) mutant of syndecan-4 (SDC4). SDC4 is a ubiquitously expressed transmembrane, heparan sulfate proteoglycan. In this study we show that the Ser179Glu mutant binds strongly Tiam1, a Rac1-GEF reducing Rac1-GTP by 3-fold in MCF-7 breast adenocarcinoma cells. Mutational analysis unravels the PDZ interaction between SDC4 and Tiam1 is indispensable for the suppression of the Rac1 activity. Neither of the SDC4 interactions is effective alone to block the Rac1 activity, on the contrary, lack of either of interactions can increase the activity of Rac1, therefore the Rac1 activity is the resultant of the inhibitory and stimulatory effects. In addition, SDC4 can bind and tether RhoGDI1 (GDP-dissociation inhibitor 1) to the membrane. Expression of the phosphomimetic SDC4 results in the accumulation of the Rac1-RhoGDI1 complex. Co-immunoprecipitation assays (co-IP-s) reveal that SDC4 can form complexes with RhoGDI1. Together, the regulation of the basal activity of Rac1 is fine tuned and SDC4 is implicated in multiple ways.
first_indexed 2024-12-20T08:23:04Z
format Article
id doaj.art-1bb2f9035c1945beab3d6c94b326feed
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T08:23:04Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1bb2f9035c1945beab3d6c94b326feed2022-12-21T19:46:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011211e018709410.1371/journal.pone.0187094The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.Aniko Keller-PinterBettina UghyMonika DomokiAladar Pettko-SzandtnerTamas LetohaJozsef TovariJozsef TimarLaszlo SzilakThe small GTPases of the Rho family comprising RhoA, Rac1 and Cdc42 function as molecular switches controlling several essential biochemical pathways in eukaryotic cells. Their activity is cycling between an active GTP-bound and an inactive GDP-bound conformation. The exchange of GDP to GTP is catalyzed by guanine nucleotide exchange factors (GEFs). Here we report a novel regulatory mechanism of Rac1 activity, which is controlled by a phosphomimetic (Ser179Glu) mutant of syndecan-4 (SDC4). SDC4 is a ubiquitously expressed transmembrane, heparan sulfate proteoglycan. In this study we show that the Ser179Glu mutant binds strongly Tiam1, a Rac1-GEF reducing Rac1-GTP by 3-fold in MCF-7 breast adenocarcinoma cells. Mutational analysis unravels the PDZ interaction between SDC4 and Tiam1 is indispensable for the suppression of the Rac1 activity. Neither of the SDC4 interactions is effective alone to block the Rac1 activity, on the contrary, lack of either of interactions can increase the activity of Rac1, therefore the Rac1 activity is the resultant of the inhibitory and stimulatory effects. In addition, SDC4 can bind and tether RhoGDI1 (GDP-dissociation inhibitor 1) to the membrane. Expression of the phosphomimetic SDC4 results in the accumulation of the Rac1-RhoGDI1 complex. Co-immunoprecipitation assays (co-IP-s) reveal that SDC4 can form complexes with RhoGDI1. Together, the regulation of the basal activity of Rac1 is fine tuned and SDC4 is implicated in multiple ways.http://europepmc.org/articles/PMC5679609?pdf=render
spellingShingle Aniko Keller-Pinter
Bettina Ughy
Monika Domoki
Aladar Pettko-Szandtner
Tamas Letoha
Jozsef Tovari
Jozsef Timar
Laszlo Szilak
The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.
PLoS ONE
title The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.
title_full The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.
title_fullStr The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.
title_full_unstemmed The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.
title_short The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.
title_sort phosphomimetic mutation of syndecan 4 binds and inhibits tiam1 modulating rac1 activity in pdz interaction dependent manner
url http://europepmc.org/articles/PMC5679609?pdf=render
work_keys_str_mv AT anikokellerpinter thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT bettinaughy thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT monikadomoki thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT aladarpettkoszandtner thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT tamasletoha thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT jozseftovari thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT jozseftimar thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT laszloszilak thephosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT anikokellerpinter phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT bettinaughy phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT monikadomoki phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT aladarpettkoszandtner phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT tamasletoha phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT jozseftovari phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT jozseftimar phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner
AT laszloszilak phosphomimeticmutationofsyndecan4bindsandinhibitstiam1modulatingrac1activityinpdzinteractiondependentmanner